Metraipolis › archive › dc_7368de86356f

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models — Europe PMC PMID:42321174

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42321174
DOI
10.1038/s41467-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-19T08:07:12.210Z
SHA-256 of the archived text
f0559f180954ef3ef062aa994b2c9822e13a6557193f68c53aa731b611b3401f
Stable URL of this page
https://metraipolis.com/documento/dc_7368de86356f

How to cite

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models — Europe PMC PMID:42321174 — Europe PMC (en), https://europepmc.org/article/MED/42321174 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7368de86356f (Metraipolis archive dc_7368de86356f, sha256 f0559f180954ef3ef062aa994b2c9822e13a6557193f68c53aa731b611b3401f)
BibTeX
@misc{dc7368de86356f,
  title = {Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models — Europe PMC PMID:42321174},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42321174},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7368de86356f; sha256 f0559f180954ef3ef062aa994b2c9822e13a6557193f68c53aa731b611b3401f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42321174. Agents can read the archived copy with the MCP tool read_document.